Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis

Podobne zapisy

• No Evidence of Association Between Anti–Tumor Necrosis Factor Treatment and Mortality in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register
  od: Lunt, Mark, i wsp.
  Wydane: (2010)
• Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population
  od: Mercer, Louise K., i wsp.
  Wydane: (2013)
• Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
  od: Mercer, Louise K, i wsp.
  Wydane: (2015)
• Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis
  od: Low, Audrey S L, i wsp.
  Wydane: (2017)
• Rituximab or a second anti–tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti–tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register
  od: Soliman, Moetaza M, i wsp.
  Wydane: (2012)